Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stefano de Biase, Giovanni Merlino, Simone Lorenzut, Mariarosaria Valente & Gian Luigi Gigli. (2014) Investigational approaches to therapies for restless legs syndrome. Expert Opinion on Investigational Drugs 23:6, pages 847-856.
Read now
Read now
Articles from other publishers (12)
Paul G. Yeh, Karen Spruyt, Lourdes M. DelRosso & Arthur S. Walters. (2023) A Narrative Review of the Lesser Known Medications for Treatment of Restless Legs Syndrome and Pathogenetic Implications for Their Use. Tremor and Other Hyperkinetic Movements 13:1.
Crossref
Crossref
Ravi Yadav, Maryam RA Altuhafy, Sandeep Talluri, Luay Jabr, Mythili Kalladka & Junad Khan. (2022) The Efficacy of Botulinum Toxin in the Management of Restless Leg Syndrome: A Systematic Review of Randomized Control Trials. Indian Journal of Sleep Medicine 17:1, pages 15-21.
Crossref
Crossref
Yu-Chi Su, Yao-Hong Guo, Chung-Lun Liao & Yu-Ching Lin. (2021) Effectiveness and Safety of Botulinum Toxin Type A in Treatment of Restless Legs Syndrome: A Systematic Review and Meta-Analysis. Healthcare 9:11, pages 1538.
Crossref
Crossref
Wolfgang H. Jost. (2021) Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal. Toxins 13:2, pages 87.
Crossref
Crossref
Shivam Mittal, Duarte Machado, Diana Richardson, Divyanshu Dubey & Bahman Jabbari. (2018) Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study. Toxins 10:10, pages 401.
Crossref
Crossref
Joseph Jankovic. (2018) An update on new and unique uses of botulinum toxin in movement disorders. Toxicon 147, pages 84-88.
Crossref
Crossref
Seerapani Gopaluni, Mohamed Sherif & Naim A Ahmadouk. (2016) Interventions for chronic kidney disease-associated restless legs syndrome. Cochrane Database of Systematic Reviews 2016:11.
Crossref
Crossref
Denise Sharon. (2015) Nonpharmacologic Management of Restless Legs Syndrome (Willis-Ekbom Disease). Sleep Medicine Clinics 10:3, pages 263-278.
Crossref
Crossref
Alan Christmann Fröhlich, Alan Luiz Eckeli, Andrea Bacelar, Dalva Poyares, Daniela Vianna Pachito, Fernando Gustavo Stelzer, Fernando Morgadinho Santos Coelho, Geraldo Nunes Vieira Rizzo, Gilmar Fernandes do Prado, Heidi Haueisen Sander, Leonardo Ierardi Goulart, Ligia Mendonça Lucchesi, Lívia Leite Góes Gitai, Lucila Bizari Fernandes do Prado, Luiz Ataíde-Junior, Marcio Luciano de Souza Bezerra, Maria Cecília Lopes, Marine Meliksetyan Trentin, Raimundo Nonato Delgado Rodrigues, Rosa Hasan, Rosana S. Cardoso Alves, Suzana Veiga Schönwald & Walter André dos Santos Moraes. (2015) Brazilian consensus on guidelines for diagnosis and treatment for restless legs syndrome. Arquivos de Neuro-Psiquiatria 73:3, pages 260-280.
Crossref
Crossref
Seerapani Gopaluni, Mohamed Sherif & Naim A Ahmadouk. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Imad Ghorayeb, Antoine Bénard, Alexandre Vivot, François Tison & Pierre Burbaud. (2012) A phase II, open-label, non-comparative study of Botulinum toxin in Restless Legs Syndrome. Sleep Medicine 13:10, pages 1313-1316.
Crossref
Crossref
Diego Garcia‐Borreguero, Luigi Ferini‐Strambi, Ralf Kohnen, Shaun O'Keeffe, Claudia Trenkwalder, Birgit Högl, Heike Benes, Poul Jennum, Markku Partinen, Danyal Fer, Pasquale Montagna, Claudio L. Bassetti, Alex Iranzo, Karel Sonka & Anne‐Marie Williams. (2012) European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. European Journal of Neurology 19:11, pages 1385-1396.
Crossref
Crossref